- Home
- GPRE vs ORGO Comparison
GPRE vs ORGO Comparison
Compare GPRE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- ORGO
- Stock Information
- Founded
- GPRE 2004
- ORGO 1985
- Country
- GPRE United States
- ORGO United States
- Employees
- GPRE N/A
- ORGO N/A
- Industry
- GPRE Major Chemicals
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- GPRE Industrials
- ORGO Health Care
- Exchange
- GPRE Nasdaq
- ORGO Nasdaq
- Market Cap
- GPRE 631.4M
- ORGO 620.3M
- IPO Year
- GPRE N/A
- ORGO N/A
- Fundamental
- Price
- GPRE $9.88
- ORGO $4.96
- Analyst Decision
- GPRE Hold
- ORGO Buy
- Analyst Count
- GPRE 7
- ORGO 2
- Target Price
- GPRE $8.21
- ORGO $7.50
- AVG Volume (30 Days)
- GPRE 2.1M
- ORGO 739.1K
- Earning Date
- GPRE 10-30-2025
- ORGO 11-11-2025
- Dividend Yield
- GPRE N/A
- ORGO N/A
- EPS Growth
- GPRE N/A
- ORGO N/A
- EPS
- GPRE N/A
- ORGO N/A
- Revenue
- GPRE $2,397,101,000.00
- ORGO $429,531,000.00
- Revenue This Year
- GPRE N/A
- ORGO $2.57
- Revenue Next Year
- GPRE N/A
- ORGO $9.80
- P/E Ratio
- GPRE N/A
- ORGO N/A
- Revenue Growth
- GPRE N/A
- ORGO N/A
- 52 Week Low
- GPRE $3.14
- ORGO $2.61
- 52 Week High
- GPRE $14.04
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- GPRE 54.71
- ORGO 54.68
- Support Level
- GPRE $9.50
- ORGO $4.75
- Resistance Level
- GPRE $11.27
- ORGO $5.10
- Average True Range (ATR)
- GPRE 0.57
- ORGO 0.21
- MACD
- GPRE -0.16
- ORGO -0.01
- Stochastic Oscillator
- GPRE 20.09
- ORGO 52.53
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.